This may have therapeutic potential in the context of neurodegenerative diseases as a way to limit the extracellular release of pathogenic proteins like Tau and α‐synuclein in favor of their intracellular degradation, which may help limit the propagation of disease (Miranda & Di Paolo, 2018). This evidence concerns the gene MAPT and neurodegenerative disease.